These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 15767525
21. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population. Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Kadota A, Kadowaki S, Kadowaki T, Yamamoto T, Miyagawa N, Zaid M, Torii S, Takashima N, Murakami Y, Okamura T, Horie M, Ueshima H, SESSA Research Group. Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580 [Abstract] [Full Text] [Related]
22. A comparison of HDL and LDL cholesterol for prevalent coronary calcification. Allison MA, Wright CM. Int J Cardiol; 2004 May; 95(1):55-60. PubMed ID: 15159039 [Abstract] [Full Text] [Related]
23. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Vrablik M, Fait T, Kovar J, Poledne R, Ceska R. Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386 [Abstract] [Full Text] [Related]
24. Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) Study. Hallman DM, Brown SA, Ballantyne CM, Sharrett AR, Boerwinkle E. Biomarkers; 2004 Aug; 9(2):190-202. PubMed ID: 15370875 [Abstract] [Full Text] [Related]
27. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides]. Posadas-Romero C, Posadas-Sánchez R, Juárez-Rojas JG, Medina-Urrutia A, Jorge-Galarza E, Cardoso-Saldaña G, Caracas-Portilla N, Mendoza-Peŕez E. Arch Cardiol Mex; 2008 Aug; 78(1):30-9. PubMed ID: 18581711 [Abstract] [Full Text] [Related]
29. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM. Metabolism; 2007 Apr; 56(4):444-50. PubMed ID: 17378998 [Abstract] [Full Text] [Related]
30. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985 [Abstract] [Full Text] [Related]
31. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P. Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536 [Abstract] [Full Text] [Related]
32. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study. Khatibi A, Agardh CD, Shakir YA, Nerbrand C, Nyberg P, Lidfeldt J, Samsioe G. Climacteric; 2007 Oct; 10(5):386-92. PubMed ID: 17852141 [Abstract] [Full Text] [Related]
33. Changes in LDL density across the menopausal transition. Carr MC, Kim KH, Zambon A, Mitchell ES, Woods NF, Casazza CP, Purnell JQ, Hokanson JE, Brunzell JD, Schwartz RS. J Investig Med; 2000 Jul; 48(4):245-50. PubMed ID: 10916282 [Abstract] [Full Text] [Related]
34. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF, Linton MF, Fazio S, Stein CM. J Rheumatol; 2010 Aug 01; 37(8):1633-8. PubMed ID: 20516025 [Abstract] [Full Text] [Related]
35. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. Grodstein F, Manson JE, Stampfer MJ. J Womens Health (Larchmt); 2006 Aug 01; 15(1):35-44. PubMed ID: 16417416 [Abstract] [Full Text] [Related]
36. Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study. Inoue Y, Zhang B, Sadamori R, Shirota K, Saku K, Kawarabayashi T. Menopause; 2008 Aug 01; 15(1):157-63. PubMed ID: 17603392 [Abstract] [Full Text] [Related]
37. LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: a randomized controlled clinical trial. Misra R, Mangi S, Joshi S, Mittal S, Gupta SK, Pandey RM. J Obstet Gynaecol Res; 2006 Jun 01; 32(3):299-304. PubMed ID: 16764620 [Abstract] [Full Text] [Related]
38. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype. Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW. Arterioscler Thromb Vasc Biol; 2004 Apr 01; 24(4):744-9. PubMed ID: 14751815 [Abstract] [Full Text] [Related]
39. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia. Kostapanos MS, Milionis HJ, Filippatos TD, Nakou ES, Bairaktari ET, Tselepis AD, Elisaf MS. Clin Ther; 2007 Jul 01; 29(7):1403-14. PubMed ID: 17825691 [Abstract] [Full Text] [Related]